E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 65.28% 45.01% 12.83% 9.25% 5.33%
Total Depreciation and Amortization 0.41% -0.82% -0.41% -0.82% 2.54%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -33.91% 13.19% 36.54% 12.04% -1.00%
Change in Net Operating Assets -238.61% -977.99% -61.54% -48.46% -96.58%
Cash from Operations 43.17% 1.06% 4.01% 8.04% 1.49%
Capital Expenditure -- -- 100.00% 15.15% 97.93%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -156.35% -144.00% -12.94% -18.23% -63.52%
Cash from Investing -156.37% -144.00% -12.81% -18.24% -63.29%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -77.63% -- -38.84% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -77.63% -- -38.84% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -72.50% -45.78% -50.94% -48.14% -235.39%